Public Announcement (NASDAQ: IXHL) (ASX
Public Announcement Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of...
Source: marketscreener.com
Page 4 - Commercialization Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Commercialization Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Commercialization Services Today - Breaking & Trending Today
Incannex engages Fortrea to Manage its FDA IND Opening
Highlights: Incannex has engaged Fortrea as the contract research organisation (‘CRO’) to manage the IND opening Phase 2/3 clinical trial investigating...
Source: globenewswire.com
LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA
/PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, previously announced the following record and distribution dates for its spin-off...
Source: prnewswire.com
LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA
BURLINGTON, N.C., June 12, 2023 /PRNewswire/ -- Labcorp , a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea... | June 13, 2023
Source: marketscreener.com
Labcorp Announces Information in Connection with its Spin-off of Fortrea
BURLINGTON, N.C., June 9, 2023 /PRNewswire/ -- Labcorp , a leading global life sciences company, today announced the following record and distribution dates for the spin-off of Fortrea Holdings... | June 10, 2023
Source: marketscreener.com